BridgeMD
New treatment option for Atrial Fibrillation (AF)
Official title Improving Outcomes After AF Ablation in Obese Patients
ClinicalTrials.gov ID: NCT07618741
What this study is testing
- What it's testing
- Improving Outcomes After AF Ablation in Obese Patients
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Patients with Class I indication of catheter ablation of paroxysmal or persistent AF and will undergo catheter ablation at National Taiwan University...
You likely can't join if
- Informed consent could not be obtained due to personal problem
- Unwillingness or inability to return for follow-up visits or reason to believe that adherence to follow-up visits wound be irregular
- Current or scheduled enrollment in other conflicting studies, and
- Concomitant disease or other medical condition likely to result in death within 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.